Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 643

1.

Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta-analysis.

Johnston A, Smith C, Zheng C, Aaron SD, Kelly SE, Skidmore B, Wells GA.

Clin Exp Allergy. 2019 Jul 11. doi: 10.1111/cea.13457. [Epub ahead of print]

PMID:
31295369
2.

Incremental Value of Implantable Cardiac Device Diagnostic Variables Over Clinical Parameters to Predict Mortality in Patients With Mild to Moderate Heart Failure.

Manlucu J, Sharma V, Koehler J, Warman EN, Wells GA, Gula LJ, Yee R, Tang AS.

J Am Heart Assoc. 2019 Jul 16;8(14):e010998. doi: 10.1161/JAHA.118.010998. Epub 2019 Jul 11.

PMID:
31291801
Free Article
3.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration [Internet].

Wells GA, Elliott J, Kelly S, Bai Z, Boucher M, Skidmore B, So D, Laplante S, Lee K.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.

4.

Dual antiplatelet therapy following percutaneous coronary intervention: protocol for a systematic review.

Elliott J, Kelly SE, Bai Z, Skidmore B, Boucher M, So DYF, Wells GA.

BMJ Open. 2019 Jun 16;9(6):e022271. doi: 10.1136/bmjopen-2018-022271.

5.

Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.

Elliott J, van Katwyk S, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D.

Pharmacoeconomics. 2019 Jun 14. doi: 10.1007/s40273-019-00816-2. [Epub ahead of print] Review.

PMID:
31201643
6.

Tramadol for osteoarthritis.

Toupin April K, Bisaillon J, Welch V, Maxwell LJ, Jüni P, Rutjes AW, Husni ME, Vincent J, El Hindi T, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2019 May 27;5:CD005522. doi: 10.1002/14651858.CD005522.pub3.

PMID:
31132298
7.

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.

Essebag V, AlTurki A, Proietti R, Healey JS, Wells GA, Verma A, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leather R, Ahmad K, Toal S, Sapp J, Sturmer M, Kavanagh K, Crystal E, Leiria TLL, Seifer C, Rinne C, Birnie D; BRUISE CONTROL Investigators.

Int J Cardiol. 2019 Aug 1;288:87-93. doi: 10.1016/j.ijcard.2019.04.066. Epub 2019 Apr 26.

PMID:
31056413
8.

Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells.

Bernatchez JA, Coste M, Beck S, Wells GA, Luna LA, Clark AE, Zhu Z, Hecht D, Rich JN, Sohl CD, Purse BW, Siqueira-Neto JL.

Viruses. 2019 Apr 20;11(4). pii: E365. doi: 10.3390/v11040365.

9.

The ART of conversation: feasibility and acceptability of a pilot peer intervention to help transition complex HIV-positive people from hospital to community.

Eaton AD, Chan Carusone S, Craig SL, Telegdi E, McCullagh JW, McClure D, Wilson W, Zuniga L, Berney K, Ginocchio GF, Wells GA, Montess M, Busch A, Boyce N, Strike C, Stewart A.

BMJ Open. 2019 Mar 30;9(3):e026674. doi: 10.1136/bmjopen-2018-026674.

10.

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.

Elliott J, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D.

Syst Rev. 2019 Mar 27;8(1):75. doi: 10.1186/s13643-019-0990-z.

11.

Spatial Abilities Training in Anatomy Education: A Systematic Review.

Langlois J, Bellemare C, Toulouse J, Wells GA.

Anat Sci Educ. 2019 Mar 6. doi: 10.1002/ase.1873. [Epub ahead of print]

PMID:
30839169
12.

Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.

Yadav K, Suh KN, Eagles D, Thiruganasambandamoorthy V, Wells GA, Stiell IG.

Am J Emerg Med. 2019 Feb 21. pii: S0735-6757(19)30107-X. doi: 10.1016/j.ajem.2019.02.023. [Epub ahead of print]

PMID:
30824277
13.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Feb 15. pii: jrheum.181096. doi: 10.3899/jrheum.181096. [Epub ahead of print]

PMID:
30770515
14.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Feb 15. pii: jrheum.181097. doi: 10.3899/jrheum.181097. [Epub ahead of print]

PMID:
30770502
15.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Feb 1. pii: jrheum.181218. doi: 10.3899/jrheum.181218. [Epub ahead of print]

PMID:
30709952
16.

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health.

Milman N, McConville E, Robson JC, Boonen A, Tugwell P, Wells GA, Chaudhuri D, Dawson J, Tomasson G, Ashdown S, Gebhart D, Lanier G, Peck J, McAlear CA, Kellom KS, Cronholm PF, Merkel PA.

J Rheumatol. 2019 Feb 1. pii: jrheum.181073. doi: 10.3899/jrheum.181073. [Epub ahead of print]

PMID:
30709951
17.

Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope.

Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, McRae AD, Arcot K, Nemnom MJ, Huang L, Mukarram M, Krahn AD, Wells GA, Taljaard M.

Circulation. 2019 Mar 12;139(11):1396-1406. doi: 10.1161/CIRCULATIONAHA.118.036088.

PMID:
30661373
18.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck A, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Jan 15. pii: jrheum.181123. doi: 10.3899/jrheum.181123. [Epub ahead of print]

PMID:
30647191
19.

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R; Contextual Factors Working Group.

J Rheumatol. 2019 Jan 15. pii: jrheum.181081. doi: 10.3899/jrheum.181081. [Epub ahead of print]

PMID:
30647174
20.

Minimally Invasive coronary surgery compared to STernotomy coronary artery bypass grafting: The MIST trial.

Guo MH, Wells GA, Glineur D, Fortier J, Davierwala PM, Kikuchi K, Lemma MG, Mishra YK, McGinn J, Ramchandani M, Rabindra P, Nambala S, Chiu KM, Kiaii B, Gibson S, Ruel M.

Contemp Clin Trials. 2019 Mar;78:140-145. doi: 10.1016/j.cct.2019.01.006. Epub 2019 Jan 8.

PMID:
30634037
21.

The use of information and communication technologies by arthritis health professionals to disseminate a self-management program to patients: a pilot randomized controlled trial protocol.

De Angelis G, Brosseau L, Davies B, King J, Wells GA.

Digit Health. 2018 Dec 17;4:2055207618819571. doi: 10.1177/2055207618819571. eCollection 2018 Jan-Dec.

22.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH.

Europace. 2018 Dec 7. doi: 10.1093/europace/euy285. [Epub ahead of print]

PMID:
30535367
23.

Systematic reviews of clinical practice guidelines: a methodological guide.

Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA.

J Clin Epidemiol. 2019 Apr;108:64-76. doi: 10.1016/j.jclinepi.2018.11.030. Epub 2018 Dec 5.

PMID:
30529647
24.

Cannabis-based products for pediatric epilepsy: A systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter BK, Skidmore B, Alexander C, Repetski AE, Shukla V, McCoy B, Wells GA.

Epilepsia. 2019 Jan;60(1):6-19. doi: 10.1111/epi.14608. Epub 2018 Dec 4.

PMID:
30515765
25.

Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Brinkhurst J, Wells GA.

CMAJ. 2018 Dec 3;190(48):E1406-E1413. doi: 10.1503/cmaj.180232.

26.

Postablation Atrial Fibrillation Burden and Patient Activity Level: Insights From the DISCERN AF Study.

Proietti R, Birnie D, Ziegler PD, Wells GA, Verma A.

J Am Heart Assoc. 2018 Dec 4;7(23):e010256. doi: 10.1161/JAHA.118.010256.

27.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
28.

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making.

Johnston A, Hsieh SC, Carrier M, Kelly SE, Bai Z, Skidmore B, Wells GA.

PLoS One. 2018 Nov 9;13(11):e0207410. doi: 10.1371/journal.pone.0207410. eCollection 2018.

29.

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.

Andrade JG, Champagne J, Deyell MW, Essebag V, Lauck S, Morillo C, Sapp J, Skanes A, Theoret-Patrick P, Wells GA, Verma A; EARLY-AF Study Investigators.

Am Heart J. 2018 Dec;206:94-104. doi: 10.1016/j.ahj.2018.05.020. Epub 2018 Oct 18.

PMID:
30342299
30.

Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation [Internet].

Wells GA, Smith C, Hossain A, Karsh J, Singh J, Hazlewood G, Tugwell P.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar.

31.

Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Review of the Clinical Impact of Treatment Duration [Internet].

Wells GA, Elliott J, Kelly S, So D, Boucher M, Bai Z, Liu W, Skidmore B.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Aug.

32.

Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians.

Couture EL, Farand P, Nguyen M, Allard C, Wells GA, Mansour S, Rinfret S, Afilalo J, Eisenberg M, Montigny M, Kouz S, Afilalo M, Lauzon C, Dery JP, L'Allier P, Schampaert E, Tardif JC, Huynh T.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E441-E448. doi: 10.1002/ccd.27877. Epub 2018 Sep 30.

PMID:
30269415
33.

Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants.

Avellaneda Matteo D, Wells GA, Luna LA, Grunseth AJ, Zagnitko O, Scott DA, Hoang A, Luthra A, Swairjo MA, Schiffer JM, Sohl CD.

Biochem J. 2018 Oct 22;475(20):3221-3238. doi: 10.1042/BCJ20180424.

PMID:
30249606
34.

Cannabis for pediatric epilepsy: protocol for a living systematic review.

Elliott J, DeJean D, Clifford T, Coyle D, Potter B, Skidmore B, Alexander C, Repetski AE, McCoy B, Wells GA.

Syst Rev. 2018 Jul 18;7(1):95. doi: 10.1186/s13643-018-0761-2. Review.

35.

Validation and refinement of a clinical decision rule for the use of computed tomography in children with minor head injury in the emergency department.

Osmond MH, Klassen TP, Wells GA, Davidson J, Correll R, Boutis K, Joubert G, Gouin S, Khangura S, Turner T, Belanger F, Silver N, Taylor B, Curran J, Stiell IG; Pediatric Emergency Research Canada (PERC) Head Injury Study Group.

CMAJ. 2018 Jul 9;190(27):E816-E822. doi: 10.1503/cmaj.170406.

36.

Coronary artery microvascular dysfunction: Role of sex and arterial load.

Coutinho T, Mielniczuk LM, Srivaratharajah K, deKemp R, Wells GA, Beanlands RS.

Int J Cardiol. 2018 Nov 1;270:42-47. doi: 10.1016/j.ijcard.2018.06.072. Epub 2018 Jun 20.

PMID:
29954671
37.

The use of social media among health professionals to facilitate chronic disease self-management with their patients: A systematic review.

De Angelis G, Wells GA, Davies B, King J, Shallwani SM, McEwan J, Cavallo S, Brosseau L.

Digit Health. 2018 May 3;4:2055207618771416. doi: 10.1177/2055207618771416. eCollection 2018 Jan-Dec. Review.

38.

The Ottawa Panel guidelines on programmes involving therapeutic exercise for the management of hand osteoarthritis.

Brosseau L, Thevenot O, MacKiddie O, Taki J, Wells GA, Guitard P, Léonard G, Paquet N, Aydin SZ, Toupin-April K, Cavallo S, Moe RH, Shaikh K, Gifford W, Loew L, De Angelis G, Shallwani SM, Aburub AS, Mizusaki Imoto A, Rahman P, Álvarez Gallardo IC, Cosic MB, Østerås N, Lue S, Hamasaki T, Gaudreault N, Towheed TE, Koppikar S, Kjeken I, Mahendira D, Kenny GP, Paterson G, Westby M, Laferrière L, Longchamp G.

Clin Rehabil. 2018 Nov;32(11):1449-1471. doi: 10.1177/0269215518780973. Epub 2018 Jun 18.

PMID:
29911409
39.

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

Coyle K, Coyle D, Nault I, Parkash R, Healey JS, Gray CJ, Gardner MJ, Sterns LD, Essebag V, Hruczkowski T, Blier L, Wells GA, Tang ASL, Stevenson WG, Sapp JL.

JACC Clin Electrophysiol. 2018 May;4(5):660-668. doi: 10.1016/j.jacep.2018.01.007. Epub 2018 Mar 28.

PMID:
29798795
40.

Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.

Elliott J, McCoy B, Clifford T, Wells GA, Coyle D.

Pharmacoeconomics. 2018 Oct;36(10):1253-1261. doi: 10.1007/s40273-018-0669-7.

PMID:
29761351
41.

Effect of coronary revascularization on long-term clinical outcomes in patients with ischemic cardiomyopathy and recurrent ventricular arrhythmia.

Elsokkari I, Parkash R, Gray CJ, Gardner MJ, AbdelWahab AM, Doucette S, Tang AS, Wells GA, Stevenson WG, Sapp JL.

Pacing Clin Electrophysiol. 2018 May 11. doi: 10.1111/pace.13375. [Epub ahead of print]

PMID:
29750365
42.

Optimal mean arterial pressure in comatose survivors of out-of-hospital cardiac arrest: An analysis of area below blood pressure thresholds.

Russo JJ, Di Santo P, Simard T, James TE, Hibbert B, Couture E, Marbach J, Osborne C, Ramirez FD, Wells GA, Labinaz M, Le May MR; from the CAPITAL study group.

Resuscitation. 2018 Jul;128:175-180. doi: 10.1016/j.resuscitation.2018.04.028. Epub 2018 Apr 22.

PMID:
29694851
43.

Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.

Hiremath S, Akbari A, Wells GA, Chow BJW.

Int Urol Nephrol. 2018 Aug;50(8):1477-1482. doi: 10.1007/s11255-018-1874-1. Epub 2018 Apr 23.

PMID:
29687326
44.

Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People's Republic of China: A cross-sectional study.

Wang J, Sun W, Wells GA, Li Z, Li T, Wu J, Zhang Y, Liu Y, Li L, Yu Y, Liu Y, Qi C, Lu Y, Liu N, Yan Y, Liu L, Hui G, Liu B.

PLoS One. 2018 Apr 5;13(4):e0195340. doi: 10.1371/journal.pone.0195340. eCollection 2018.

45.

Mental Health Screening and Differences in Access to Care among Prisoners.

Martin MS, Crocker AG, Potter BK, Wells GA, Grace RM, Colman I.

Can J Psychiatry. 2018 Oct;63(10):692-700. doi: 10.1177/0706743718762099. Epub 2018 Feb 28.

46.

The knitting community-based trial for older women with osteoarthritis of the hands: design and rationale of a randomized controlled trial.

Guitard P, Brosseau L, Wells GA, Paquet N, Paterson G, Toupin-April K, Cavallo S, Aydin SZ, Léonard G, De Angelis G.

BMC Musculoskelet Disord. 2018 Feb 14;19(1):56. doi: 10.1186/s12891-018-1965-2.

47.

Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery.

Russo JJ, James TE, Ruel M, Dupuis JY, Singh K, Goubran D, Malhotra N, Rubens F, Chong AY, Hibbert B, Boland P, Tran DT, Tanguay JF, Lordkipanidzé M, Perrault L, Wells GA, Bourke M, Chan V, So DY; CArdiovascular Percutaneous Intervention TriAL (CAPITAL) investigators.

Eur Heart J Acute Cardiovasc Care. 2018 Jan 1:2048872617740832. doi: 10.1177/2048872617740832. [Epub ahead of print]

PMID:
29313713
48.

Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).

Jolly SS, Gao P, Cairns JA, Yusuf S, Bhatt DL, Wyse DG, Wells GA, Džavík V.

Circulation. 2018 Jan 9;137(2):206-209. doi: 10.1161/CIRCULATIONAHA.117.030656. No abstract available.

PMID:
29311352
49.

Decision curve analysis as a framework to estimate the potential value of screening or other decision-making aids.

Martin MS, Wells GA, Crocker AG, Potter BK, Colman I.

Int J Methods Psychiatr Res. 2018 Mar;27(1). doi: 10.1002/mpr.1601. Epub 2017 Dec 28.

PMID:
29282797
50.

Prospective, Cluster-Randomized Trial to Implement the Ottawa Model for Smoking Cessation in Diabetes Education Programs in Ontario, Canada.

Reid RD, Malcolm J, Wooding E, Geertsma A, Aitken D, Arbeau D, Blanchard C, Gagnier JA, Gupta A, Mullen KA, Oh P, Papadakis S, Tulloch H, LeBlanc AG, Wells GA, Pipe AL.

Diabetes Care. 2018 Mar;41(3):406-412. doi: 10.2337/dc17-1809. Epub 2017 Dec 21.

PMID:
29269509

Supplemental Content

Loading ...
Support Center